摘要 |
Six single nucleotide polymorphisms (SNPs) are found to be associated with schizophrenia. The applications of these SNPs, and genetic markers in the same haplotype as, or linkage disequilibrium with, one or more of these six SNPs to diagnostic and drug development purposes are described in the present invention.
|